Encore sells consumer line
This article was originally published in The Gray Sheet
Executive Summary
Austin, Texas-based firm plans to strengthen its surgical implant and orthopedic rehabilitation businesses with proceeds generated from the divestiture of its consumer products line. Encore Medical announced June 9 an agreement to sell its Slendertone electrical stimulation muscle toning product line to original Irish developer Bio-Medical Research Limited for $6.8 mil. Encore obtained the U.S. distribution rights to Slendertone when it acquired Compex Technologies in February (1"The Gray Sheet" March 6, 2006, p. 11). Bio-Medical Research Limited already manufacturers, distributes and owns all intellectual property rights to the product line...
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.